Abderrazzak Merzouki
Chief Tech/Sci/R&D Officer bei SUNSHINE BIOPHARMA, INC.
Vermögen: 7 003 $ am 31.03.2024
Profil
Abderrazzak Merzouki is currently the Chief Science Officer & Director at Sunshine Biopharma, Inc. since 2016.
He is also currently a Senior Scientist at Imperial College London since 2007.
Previously, he worked as the Director-Cell Engineering & Biotherapeutics at Hydrogen Future Corp.
Dr. Merzouki holds a graduate and doctorate degree from the University of Quebec and a doctorate degree from Institut Armand-Frappier.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.03.2024 | 116 720 ( 0,12% ) | 7 003 $ | 31.03.2024 |
Aktive Positionen von Abderrazzak Merzouki
| Unternehmen | Position | Beginn |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 25.01.2024 |
| Imperial College London | Corporate Officer/Principal | 04.02.2011 |
Ehemalige bekannte Positionen von Abderrazzak Merzouki
| Unternehmen | Position | Ende |
|---|---|---|
| HYDROGEN FUTURE CORP | Corporate Officer/Principal | - |
Ausbildung von Abderrazzak Merzouki
| University of Quebec | Doctorate Degree |
| Institut Armand-Frappier | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SUNSHINE BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Hydrogen Future Corp.
 Hydrogen Future Corp. Agricultural Commodities/MillingProcess Industries Hydrogen Future Corp. operates as a holding company. The firm engages in the provision of contract research and laboratory services. It provides alternate energy generation products and services. The company was founded on June 21, 2006 and is headquartered in Houston, TX. | Process Industries |
